Skip to content
MedsAcross

Molecule

Dimethyl sulfoxide

Available on requestNephrology and urology
Presentations
2
Brands
1
Manufacturers
1
Available from stock
0

Dimethyl sulfoxide is a prescription medicine indicated for the symptomatic relief of patients with interstitial cystitis. It is available as irrigation solution for intravesical use. MedsAcross supplies Dimethyl sulfoxide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

ATC classification
G04BX13 Dimethyl sulfoxide · Urology medicines, subgroup G04B, subgroup G04BXM02AX03 Dimethyl sulfoxide · Topical treatments for joint and muscle pain, subgroup M02A, subgroup M02AX
US FDA first approval
4 April 1978
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Intravesical
Dosage forms
Irrigation solution
Identifiers
UNII YOW8V9698HRxCUI 3455CAS 67-68-5DrugBank DB01093Q407927

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

RIMSO-50 ® (dimethyl sulfoxide) is indicated for the symptomatic relief of patients with interstitial cystitis. RIMSO-50 ® has not been approved as being safe and effective for any other indication. There is no clinical evidence of effectiveness of dimethyl sulfoxide in the treatment of bacterial infections of the urinary tract.

Source: US FDA prescribing information

Dosing overview

Instillation of 50 mL of RIMSO-50 ® (dimethyl sulfoxide) directly into the bladder may be accomplished by catheter or asepto syringe and allow to remain for 15 minutes. Application of an analgesic lubricant gel such as lidocaine jelly to the urethra is suggested prior to insertion of the catheter to avoid spasm. The medication is expelled by spontaneous voiding. It is recommended that the treatment be repeated every two weeks until maximum symptomatic relief is obtained. Thereafter, time intervals between therapy may be increased appropriately. Administration of oral analgesic medication or suppositories containing belladonna and opium prior to the instillation of RIMSO-50 ® can reduce bladder spasm.

Source: US FDA prescribing information

Warnings and precautions

Dimethyl sulfoxide can initiate the liberation of histamine and there has been occasional hypersensitivity reaction with topical administration of dimethyl sulfoxide. This hypersensitivity has been reported in one patients receiving intravesical RIMSO-50 ®. The physician should be cognizant of this possibility in prescribing RIMSO-50 ®. If anaphylactoid symptoms develop, appropriate therapy should be instituted.

Source: US FDA prescribing information

Side effects

A garlic-like taste may be noted by the patient within a few minutes after instillation of RIMSO-50 ® (dimethyl sulfoxide). This taste may last several hours and because of the presence of metabolites, an odor on the breath and skin may remain for 72 hours. Transient chemical cystitis has been noted following instillation of dimethyl sulfoxide. The patient may experience moderately severe discomfort on administration. Usually this becomes less prominent with repeated administration.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

2 presentations of Dimethyl sulfoxide, sorted by availability.

MedicineManufacturerRegisterAvailability
Dimethyl sulfoxide 0.54 g/mL irrigation solutionIntravesicalGeneric name—US FDAAvailable on request
Rimso-50 0.54 g/mL irrigation solutionIntravesicalMylan InstitutionalUS FDAAvailable on request

Brands by market

1 brand names across 1 markets.

Brand names by country

United States

Manufacturers

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 4 April 1978Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Questions and answers

Is Dimethyl sulfoxide available for export from India?

Yes, on request. MedsAcross lists 2 presentations of Dimethyl sulfoxide and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Dimethyl sulfoxide have?

The catalogue lists 1 brand names for Dimethyl sulfoxide, including Rimso-50.

Is Dimethyl sulfoxide approved by the US FDA?

Yes. The US FDA first approved Dimethyl sulfoxide on 4 April 1978, according to Drugs@FDA.

Does Dimethyl sulfoxide need cold chain shipping?

No listed presentation of Dimethyl sulfoxide is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

Which ATC class is Dimethyl sulfoxide in?

Dimethyl sulfoxide is classified under ATC code G04BX13 (Dimethyl sulfoxide).

References

  1. RIMSO-50 prescribing information (Mylan Institutional). U.S. National Library of Medicine, DailyMed. Retrieved 17 March 2021

Request Dimethyl sulfoxide for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.